UPD (OTCMKTS:UPDC) & Global Cord Blood (OTCMKTS:CO) Head-To-Head Review

UPD (OTCMKTS:UPDC) and Global Cord Blood (NYSE:CO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for UPD and Global Cord Blood, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UPD 0 0 0 0 N/A
Global Cord Blood 0 0 0 0 N/A

Earnings & Valuation

This table compares UPD and Global Cord Blood’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
UPD N/A N/A -$100,000.00 N/A N/A
Global Cord Blood $147.03 million 4.77 $43.38 million N/A N/A

Global Cord Blood has higher revenue and earnings than UPD.

Profitability

This table compares UPD and Global Cord Blood’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
UPD N/A N/A N/A
Global Cord Blood 29.56% 8.84% 4.65%

Insider & Institutional Ownership

17.1% of Global Cord Blood shares are held by institutional investors. 10.9% of UPD shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Dividends

Global Cord Blood pays an annual dividend of $0.08 per share and has a dividend yield of 1.4%. UPD does not pay a dividend.

Risk & Volatility

UPD has a beta of -0.14, indicating that its share price is 114% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500.

Summary

Global Cord Blood beats UPD on 8 of the 9 factors compared between the two stocks.

About UPD

As of December 31, 2017, UPD Holding Corp. was acquired by Record STREET Brewing Company, in a reverse merger transaction. UPD Holding Corp. focuses on providing blend meal replacements, dietary specialty foods, and nutraceuticals. It intends to offer Catalyst, which provides essential vitamins and plant compounds that are necessary to aid in metabolic functions; Mini-Meal that offers the essential whey protein isolate intake; Multi-Pro, which provides essential broad-spectrum vitamins and minerals; and BittX that is used to reform the body's disposition toward bitter foods. The company was formerly known as Esio Water & Beverage Development Corp. and changed its name to UPD Holding Corp. in December 2015. The company was founded in 2013 and is based in Reno, Nevada. As of December 31, 2017, UPD Holding Corp. operates as a subsidiary of Record STREET Brewing Company.

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).

Receive News & Ratings for UPD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UPD and related companies with MarketBeat.com's FREE daily email newsletter.